Related references
Note: Only part of the references are listed.Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Plasma lecithin:cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men
R. P. F. Dullaart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
High Pre-β1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol
Amar A. Sethi et al.
CLINICAL CHEMISTRY (2010)
5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice
Marcelo J. A. Amar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Laurent Yvan-Charvet et al.
SCIENCE (2010)
Acyl-coenzyme A: cholesterol acyltransferases
Ta-Yuan Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans
Laura Calabresi et al.
CIRCULATION (2009)
Lecithin: Cholesterol Acyltransferase and Atherosclerosis Another High-Density Lipoprotein Story That Doesn't Quite Follow the Script
Daniel J. Rader
CIRCULATION (2009)
Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In Vivo
Hiroyuki Tanigawa et al.
CIRCULATION (2009)
High-Density Lipoprotein/Apolipoprotein A-I Infusion Therapy
Jean-Claude Tardif et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions
E. Van Craeyveld et al.
GENE THERAPY (2009)
Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein
Marcelo J. A. Amar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease
Xavier Rousset et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Plasma Lecithin: Cholesterol Acyltransferase Activity Is Elevated in Metabolic Syndrome and Is an Independent Marker of Increased Carotid Artery Intima Media Thickness
Robin P. F. Dullaart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Xun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Human lecithin: Cholesterol acyltransferase deficiency - In vivo kinetics of low-density lipoprotein and lipoprotein-X
Masato Nishiwaki et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Tangier disease: still more questions than answers
JR Nofer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Compromised LCAT function is associated with increased atherosclerosis
GK Hovingh et al.
CIRCULATION (2005)
Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up
AF Ayyobi et al.
ATHEROSCLEROSIS (2004)
Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography
J Frohlich et al.
CLINICAL CHEMISTRY (2003)
Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition
JW Furbee et al.
ATHEROSCLEROSIS (2002)
Oxidative stress is markedly elevated in lecithin:cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein E knockout background in association with a reduction in atherosclerosis
DS Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice
JW Furbee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice
G Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)